| A Study of AMG 951 [rhApo2L/TRAIL] in Subjects With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy +/- Bevacizumab (NCT00508625) | Amgen | 2006-06-01 |
| Gated Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Inoperable NSCLC (NCT00692380) | Virginia Commonwealth University | 2006-06-01 |
| Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT00678964) | LungenClinic Grosshansdorf | 2006-06-01 |
| Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT) (NCT00462995) | University Health Network, Toronto | 2006-05-01 |
| Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung Cancer (NCT00578149) | Dana-Farber Cancer Institute | 2006-05-01 |
| ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer (NCT00312377) | Genzyme, a Sanofi Company | 2006-05-01 |
| Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC) (NCT01282450) | Maastricht Radiation Oncology | 2006-05-01 |
| Dose-Dense Induction/Neoadjuvant Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer (NCT02157116) | Duke University | 2006-05-01 |
| Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy (NCT00300729) | University Hospital, Linkoeping | 2006-05-01 |
| Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung Cancer (NCT00536861) | Amsterdam UMC, location VUmc | 2006-05-01 |
| Integrated Versus Standard Palliative Care in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) (NCT01038271) | Massachusetts General Hospital | 2006-05-01 |
| Alimta and Gemcitabine in Non-Small Cell Lung Cancer (NCT00434135) | Southern Italy Cooperative Oncology Group | 2006-05-01 |
| A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer (NCT00325494) | Morphotek | 2006-05-01 |
| Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC) (NCT00684099) | Hellenic Oncology Research Group | 2006-05-01 |
| Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC) (NCT00418704) | Groupe Francais De Pneumo-Cancerologie | 2006-05-01 |
| CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer (NCT00643318) | Accuray Incorporated | 2006-04-01 |
| Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC) (NCT00440414) | Hellenic Oncology Research Group | 2006-04-01 |
| A Study of Bevacizumab in Combination With First- or Second-Line Therapy in Subjects With Treated Brain Metastases Due to Non-Squamous NSCLC (PASSPORT) (NCT00312728) | Genentech, Inc. | 2006-03-01 |
| Feasibility of Exercise With Post-Op Lung Cancer Patients (NCT00636571) | Duke University | 2006-03-01 |
| Safety Evaluation of Panitumumab and Sirolimus in Advanced Non-Small Cell Lung Cancer (NCT00352950) | Amgen | 2006-03-01 |
| Stereotactic Radiotherapy (SBRT) of Lung Metastasis (NCT01803542) | University Health Network, Toronto | 2006-03-01 |
| Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung Cancer (NCT00312819) | Hadassah Medical Organization | 2006-03-01 |
| First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia (NCT00322452) | AstraZeneca | 2006-03-01 |
| A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT00556322) | Hoffmann-La Roche | 2006-03-01 |
| Survival Study of Docetaxel and Carboplatin as Neo-Adjuvant Vs Adjuvant Chemotherapy in Early Stage NSLC (NCT00321334) | Chinese Society of Lung Cancer | 2006-03-01 |
| First Line Chemotherapy Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT00308750) | Eli Lilly and Company | 2006-03-01 |
| Study of Docetaxel/Gemcitabine Followed by Chemo-radiotherapy (Chemo-RT), With or Without Consolidation Chemotherapy, in IIIA/IIIB Non Small Cell Lung Cancer (NSCLC) (NCT00431613) | Hellenic Oncology Research Group | 2006-03-01 |
| Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLC (NCT00319800) | Gachon University Gil Medical Center | 2006-02-01 |
| Pegylated Liposomal Doxorubicin and Carboplatin as First Line Treatment for Patients With Advanced Non-small Cell Lung Cancer (NCT01051362) | The First Affiliated Hospital of Guangzhou Medical University | 2006-02-01 |
| A Study of Serum Protein Profiling in Patients With Non-Small Cell Lung Cancer Treated With Gefitinib or Erlotinib (NCT00717847) | National University Hospital, Singapore | 2006-02-01 |
| Evaluation of Pemetrexed Combined With Cisplatin and Radiotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT00497315) | University Hospital, Antwerp | 2006-02-01 |
| Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC (NCT00516100) | Aptium Oncology Research Network | 2006-01-01 |
| A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT00556712) | Hoffmann-La Roche | 2006-01-01 |
| First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene (NCT00339586) | Universitair Ziekenhuis Brussel | 2006-01-01 |
| Metronomic Oral Vinorelbine in Patients With Metastatic Tumors (NCT00278070) | Hellenic Cooperative Oncology Group | 2006-01-01 |
| Phase II Trial of Tarceva in Patients With Non-Small Cell Lung Cancer (NCT00466284) | Grupo Gallego de Cancer de Pulmon | 2006-01-01 |
| A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS) (NCT00257608) | Genentech, Inc. | 2006-01-01 |
| Avastin/Docetaxel/Carboplatin in Non-Small Cell Lung Cancer (NCT00271505) | M.D. Anderson Cancer Center | 2005-12-05 |
| Effects of Selected Vegetable and Herb Mix (SV) on Advanced Non-small Cell Lung Cancer (NCT00246727) | Sun Farm Corporation | 2005-12-01 |
| Study of XL999 in Patients With Non-small Cell Lung Cancer (NCT00277329) | Symphony Evolution, Inc. | 2005-12-01 |
| Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung Cancer (NCT00529100) | Eli Lilly and Company | 2005-12-01 |
| Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NCT00268970) | Agennix | 2005-12-01 |
| Evaluation of Tolerability of Adjuvant Cisplatin/Docetaxel in Completely Resected Stage IB/II Non-Small Cell Lung Cancer (NCT00434668) | University Hospital, Antwerp | 2005-12-01 |
| Feasibility Study of Pemetrexed in Combination With Cisplatin or Carboplatin as Adjuvant Treatment of Non-Small Cell Lung Cancer (NCT00269152) | Eli Lilly and Company | 2005-12-01 |
| Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer (NCT00219297) | Novartis Pharmaceuticals | 2005-11-16 |
| A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC (NCT00251524) | Veeda Oncology | 2005-11-01 |
| Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer (NCT00259285) | Eli Lilly and Company | 2005-11-01 |
| UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer (NCT01037998) | Taipei Veterans General Hospital, Taiwan | 2005-11-01 |
| Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer (NCT00243867) | American Regent, Inc. | 2005-11-01 |
| A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung Cancer (NCT00251446) | Veeda Oncology | 2005-10-01 |
| Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients (NCT00327288) | AmpliMed Corporation | 2005-10-01 |
| Role of PET CT in Determining Target Volumes in Radiation Therapy for Lung Cancer (NCT00221169) | Toronto Sunnybrook Regional Cancer Centre | 2005-10-01 |
| A Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE) (NCT00318136) | Genentech, Inc. | 2005-09-01 |
| A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer (NCT00113516) | Pfizer | 2005-09-01 |
| PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC) (NCT00173524) | National Taiwan University Hospital | 2005-09-01 |
| Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell Lung Cancer (NCT00179699) | Celgene Corporation | 2005-09-01 |
| Radiotherapy for NSCLC to a Individualized MLD (NCT00573040) | Maastricht Radiation Oncology | 2005-08-01 |
| Methylation Status of CD44 Promoter Region in Primary Lung Cancer (NCT00173680) | National Taiwan University Hospital | 2005-08-01 |
| Minimum Dose Computed Tomography of the Thorax for Follow-up in Patients With Resected Lung Carcinoma (NCT00188279) | University Health Network, Toronto | 2005-06-21 |
| A Study to Evaluate the Efficacy of Bevacizumab in Combination With Tarceva for Advanced Non-Small Cell Lung Cancer (NCT00130728) | Genentech, Inc. | 2005-06-08 |
| Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer (NCT00118144) | National Cancer Institute (NCI) | 2005-06-01 |
| Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA NSCLC (NCT00291850) | Central European Cooperative Oncology Group | 2005-06-01 |
| A Feasibility Study of Oral Adjuvant Chemotherapy With S-1 (NCT01459185) | Tomoshi Tsuchiya | 2005-06-01 |
| Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin - Etoposide /Carboplatin in Extensive Small Cell Lung Cancer (SCLC) (NCT00240097) | University of Alabama at Birmingham | 2005-06-01 |
| Combination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With Chemotherapy (NCT00456833) | Novartis Pharmaceuticals | 2005-06-01 |
| Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer (NCT00165334) | Dana-Farber Cancer Institute | 2005-06-01 |
| Individualized Treatment Based on Epidermal Growth Factor Receptor Mutations and Level of BRCA1 Expression in Advanced Adenocarcinoma (NCT00883480) | Spanish Lung Cancer Group | 2005-06-01 |
| Molecular Profiling in Lung Cancer Patients (NCT00191308) | Eli Lilly and Company | 2005-05-01 |
| Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer (NCT00216203) | Nasser Hanna, M.D. | 2005-05-01 |
| Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC) (NCT00153803) | Dartmouth-Hitchcock Medical Center | 2005-05-01 |
| Detection of Early Lung Cancer by Serum Protein Expression Profiling (NCT00175578) | University of British Columbia | 2005-05-01 |
| Web-based Intervention for Lung Cancer Patients and Their Informal Caregivers (NCT00365963) | University of Wisconsin, Madison | 2005-04-01 |
| K-RAS Oncogene Mutation in Patients With Advanced Non-Small Cell Lung Cancer Associated With Exposure to Wood Smoke and Tobacco Smoking: Therapeutic Implications (NCT01023828) | National Institute of Cancerología | 2005-04-01 |
| A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC) (NCT00172042) | Novartis Pharmaceuticals | 2005-03-01 |
| Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer (NCT00203931) | University of Chicago | 2005-03-01 |
| Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer (NCT00173875) | National Taiwan University Hospital | 2005-03-01 |
| Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer (NCT01004601) | Chang Gung Memorial Hospital | 2005-03-01 |
| Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer. (NCT00160043) | Bayer | 2005-03-01 |
| Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC) (NCT00102804) | Eli Lilly and Company | 2005-03-01 |
| A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer (NCT00179686) | Celgene Corporation | 2005-03-01 |
| Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT00094861) | Swedish Orphan Biovitrum | 2005-01-01 |
| Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer (NCT00095199) | Eli Lilly and Company | 2005-01-01 |
| Imatinib Mesylate and Docetaxel in Non-Small Cell Lung Cancer (NSCLC) (NCT01083589) | M.D. Anderson Cancer Center | 2005-01-01 |
| Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT00094835) | Amgen | 2005-01-01 |
| An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT00949910) | Hoffmann-La Roche | 2004-11-01 |
| Erlotinib in Women With Previously Untreated Adenocarcinoma of the Lung (NCT00137839) | Pasi A. Janne, MD, PhD | 2004-11-01 |
| Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer (NCT00260026) | Memorial Sloan Kettering Cancer Center | 2004-11-01 |
| Maximum Tolerated Dose, Safety and Efficacy of Docetaxel / Cisplatin + STI571 (NCT02127372) | Duke University | 2004-11-01 |
| Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) (NCT00097227) | Eli Lilly and Company | 2004-11-01 |
| A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) (NCT00138658) | Achieve Life Sciences | 2004-11-01 |
| Computer-Generated Quality of Life Assessment Program for Advanced Non-Small Cell Lung Cancer Patients (LUNL2) (NCT01337102) | University Health Network, Toronto | 2004-11-01 |
| Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer (NCT00150657) | St. John Providence Health System | 2004-11-01 |
| Non-small Cell Lung Cancer Registry (NCT00099541) | Novartis Pharmaceuticals | 2004-11-01 |
| Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLC (NCT00378404) | Susanne Arnold | 2004-11-01 |
| Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) (NCT00097214) | Eli Lilly and Company | 2004-11-01 |
| SERPIN D1 and Its Role in Lung Cancer Invasion and Metastasis (NCT00155116) | National Taiwan University Hospital | 2004-10-01 |
| Safety Study: Combined Modality Treatment for Non-Small Cell Lung Cancer (NCT00265603) | Atlantic Health System | 2004-10-01 |
| To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therapy in Patients With Non-small Cell Lung Cancer (NSCLC) (NCT00191191) | Eli Lilly and Company | 2004-10-01 |
| NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine (NCT00199849) | Ludwig Institute for Cancer Research | 2004-09-27 |
| Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients With Advanced Lung Cancer (NCT00735878) | Konstantin Dragnev | 2004-09-01 |